These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32937035)

  • 1. Ethical and Regulatory Concerns in Pragmatic Clinical Trial Monitoring and Oversight.
    Roberts MK; Fisher DM; Parker LE; Darnell D; Sugarman J; Carrithers J; Weinfurt K; Jurkovich G; Zatzick D
    Ethics Hum Res; 2020 Sep; 42(5):29-37. PubMed ID: 32937035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory and ethical considerations for linking clinical and administrative databases.
    Dokholyan RS; Muhlbaier LH; Falletta JM; Jacobs JP; Shahian D; Haan CK; Peterson ED
    Am Heart J; 2009 Jun; 157(6):971-82. PubMed ID: 19464406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Institutional review board consideration of chart reviews, case reports, and observational studies.
    Neff MJ
    Respir Care; 2008 Oct; 53(10):1350-3. PubMed ID: 18811999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Informed consent for research and authorization under the Health Insurance Portability and Accountability Act Privacy Rule: an integrated approach.
    Shalowitz D; Wendler D
    Ann Intern Med; 2006 May; 144(9):685-8. PubMed ID: 16670138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health Insurance Portability Accountability Act (HIPAA) regulations: effect on medical record research.
    O'Herrin JK; Fost N; Kudsk KA
    Ann Surg; 2004 Jun; 239(6):772-6; discussion 776-8. PubMed ID: 15166956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethical issues in pragmatic randomized controlled trials: a review of the recent literature identifies gaps in ethical argumentation.
    Goldstein CE; Weijer C; Brehaut JC; Fergusson DA; Grimshaw JM; Horn AR; Taljaard M
    BMC Med Ethics; 2018 Feb; 19(1):14. PubMed ID: 29482537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the Nature of IRB Contingencies Required for Informed Consent Document Approval.
    Blackwood RA; Maio RF; Mrdjenovich AJ; VandenBosch TM; Gordon PS; Shipman EL; Hamilton TA
    Account Res; 2015; 22(4):237-45. PubMed ID: 25897768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ethics of using QI methods to improve health care quality and safety.
    Baily MA; Bottrell M; Lynn J; Jennings B; Hastings Center
    Hastings Cent Rep; 2006; 36(4):S1-40. PubMed ID: 16898359
    [No Abstract]   [Full Text] [Related]  

  • 10. What should IRBs consider when applying the privacy rule to research?
    Gerlach JW
    Kennedy Inst Ethics J; 2002 Sep; 12(3):299-303. PubMed ID: 12472082
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in the institutional review board submission process for multicenter research over 6 years.
    Pogorzelska M; Stone PW; Cohn EG; Larson E
    Nurs Outlook; 2010; 58(4):181-7. PubMed ID: 20637931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The IRB process needs to be reexamined.
    Esaki R; Macario A; Harrison TK; Brock-Utne JG
    Anesth Analg; 2011 May; 112(5):1249-50. PubMed ID: 21515655
    [No Abstract]   [Full Text] [Related]  

  • 13. The Practice of Research Ethics in Lebanon and Qatar: Perspectives of Researchers on Informed Consent.
    Nakkash R; Qutteina Y; Nasrallah C; Wright K; El-Alti L; Makhoul J; Al-Ali K
    J Empir Res Hum Res Ethics; 2017 Dec; 12(5):352-362. PubMed ID: 28905673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transitioning to the National Institutes of Health single institutional review board model: Piloting the use of the Streamlined, Multi-site, Accelerated Resources for Trials IRB Reliance.
    Vardeny O; Hernandez AF; Cohen LW; Franklin A; Baqai M; Palmer S; Bierer BE; Cobb N
    Clin Trials; 2019 Jun; 16(3):290-296. PubMed ID: 30866676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Streamlining the institutional review board process in pragmatic randomized clinical trials: challenges and lessons learned from the Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) trial.
    Marquis-Gravel G; Robertson H; Jones WS; Riley D; Ford DE; Crenshaw D; Joosten YA; Rudov L; Hernandez AF; Hess R
    Trials; 2021 Jan; 22(1):90. PubMed ID: 33494785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIPAA and what institutional review boards (IRBs) do not have to review.
    Maloney DM
    Hum Res Rep; 2003 Dec; 18(12):1-2. PubMed ID: 15027429
    [No Abstract]   [Full Text] [Related]  

  • 17. HIPAA--Implications for research.
    Erlen JA
    Orthop Nurs; 2005; 24(2):139-42. PubMed ID: 15902013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Researching the Appropriateness of Care in the Complementary and Integrative Health Professions Part 2: What Every Researcher and Practitioner Should Know About the Health Insurance Portability and Accountability Act and Practice-based Research in the United States.
    Iyiewuare PO; Coulter ID; Whitley MD; Herman PM
    J Manipulative Physiol Ther; 2018; 41(9):807-813. PubMed ID: 30755332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Informed consent and clinical research involving children and adolescents: implications of the revised APA ethics code and HIPAA.
    Fisher CB
    J Clin Child Adolesc Psychol; 2004 Dec; 33(4):832-9. PubMed ID: 15498750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuing oversight through site monitoring: experiences of an institutional ethics committee in an Indian tertiary-care hospital.
    Shetty YC; Marathe P; Kamat S; Thatte U
    Indian J Med Ethics; 2012; 9(1):22-6. PubMed ID: 22319848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.